• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Illumina

Illumina

Illumina Inc ILMN 3 Star

Last Price$195.60Day Change (%)-1.17%
Open Price$199.11Day Change ($)-2.32
Day Range194.65–200.0052-Week Range145.12–242.37

As of Thu 9/3/2015 2:25:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  1. Illumina , Warburg Pincus, and Sutter Hill Ventures Form Helix to Accelerate Consumer Adoption of Genomics

    Illumina , Warburg Pincus, and Sutter Hill Ventures Form Helix to Accelerate Consumer Adoption of Genomics

  2. Illumina Accelerator Invests in Second Class of Genomics Startups from US and Europe

    Illumina Accelerator Invests in Second Class of Genomics Startups from US and Europe

  3. UPDATE: RainDance pulls IPO citing market conditions

    UPDATE: RainDance pulls IPO citing market conditions

  4. RainDance pulls IPO, citing market conditions

    RainDance pulls IPO, citing market conditions

  5. Research and Markets: Global Automated Microbiology Market 2015-2019 - Examines Key Trends in the U.S, Five Major European Countries and Japan

    Research and Markets: Global Automated Microbiology Market 2015-2019 - Examines Key Trends in the U.S, Five Major European Countries and Japan

  6. Tuttle Tactical Management Weekly Market Notes

    Illumina ILMN reported second-quarter results Tuesday that beat our expectations, and we plan to raise our fair value estimate by several dollars per share. Revenue totaled $84.5 million for the quarter, a 103% increase from the year-ago period, which prompted the firm to significantly raise its ...

  7. Leader in Genomic Sequencing Illuminates the Way

    Continued technology advancements and market expansion support Illumina's narrow moat.

  8. Research and Markets: US Molecular Diagnostic Product Suppliers 2015 - Sales and Market Shares by Test

    Research and Markets: US Molecular Diagnostic Product Suppliers 2015 - Sales and Market Shares by Test

  9. Research and Markets: US Automated Microbiology Market 2015-2019 - Competitive Strategies, Supplier Shares, Country Segment Forecasts, Innovative Technologies & Instrumentation Review

    Research and Markets: US Automated Microbiology Market 2015-2019 - Competitive Strategies, Supplier Shares, Country Segment Forecasts, Innovative Technologies & Instrumentation Review

  10. 3 Big Moat Rating Changes From 2014

    Competitive advantages have improved for Mead Johnson, while De La Rue's moat was downgraded to narrow and POSCO was deemed a no-moat company.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.